Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 40,930 shares at $18.66 ($748K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Seasonal sale ($748k) by SVP, Business Development — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.66 | 3,845 | $72K | 9.6% |
| 2 | $18.66 | 3,845 | $72K | 9.6% |
| 3 | $18.19 | 16,620 | $302K | 40.4% |
| 4 | $18.19 | 16,620 | $302K | 40.4% |
| Total | $18.28 avg | 40,930 | $748K | 100% |
| Filing → |
| VNDA | SELL | 2023-03-06 | $209K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2020-03-04 | $363K | — | Filing → |